InSilico Drug Repurposing Approach To Identify Drugs For The Treatment Of Neglected Diseases using PRinS3® Platform

Chagas Disease can be described as a condition in which the parasite named Trypanosoma cruzi is involved and is the main causative agent of this disease.

Identifying New Chemical Entities as Potential Therapeutic Agent for NAFLD Treatment using PRinS3® Platform

Non-alcoholic fatty liver disease, a chronic liver condition not caused by alcohol or other obvious liver-damaging factors, is characterized by excessive fat deposition in hepatocytes.

Exploring Natural Products that inhibit the Target Biliverdin Reductase in Hyperbilirubinemia using PRinS3® Platform

Hyperbilirubinemia is a form of illness characterized by an increase in blood bilirubin levels as a result of a failure to efficiently metabolize or eliminate bilirubin, a byproduct of erythrocyte breakdown. It can be traced back to irregularities in normal bilirubin metabolism.